%0 Generic
%T Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes.
%A Hassan, Raffit
%A Mian, Idrees
%A Wagner, Cathy
%A Mallory, Yvonne
%A Agra, Maria
%A Padiernos, Emerson
%A Sengupta, Manjistha
%A Morrow, Betsy
%A Wei, Jun S.
%A Thomas, Anish
%A Steinberg, Seth M.
%A Khan, Javed
%A Ghafoor, Azam
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2020
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation